Deadline: 11 October 2018

The European & Developing Countries Clinical Trials Partnership (EDCTP) is currently seeking proposals for a programme entitled “Diagnostic tools for poverty-related diseases”.

Projects should focus on validation of the clinical performance and/or implementation of new or improved diagnostic tools and technologies for the detection of any of the PRDs, including co-infections. The proposed tools and technologies should improve the performance of diagnosis, prediction, monitoring, intervention or assessment of therapeutic response, with a significant impact on clinical decision and health outcomes. Proposals should focus on late stage development (e.g. evaluation and/or demonstration phase trials) or implementation studies in sub-Saharan Africa. Diagnostic algorithms to detect multiple infections are also welcome. Additionally, proposals should provide detailed plans for the uptake of the diagnostic tools and technologies upon successful completion of the project, including engagement with WHO or other relevant policy makers as well as plans for product registration (i.e. CE mark).

Funding Information

• The call budget is €18 million.
• The EDCTP considers that proposals requesting a contribution from the EDCTP of between EUR 1 and 3 million would allow this specific challenge to be addressed appropriately.
• EDCTP considers that proposals of between 24 and 48 months duration would allow this specific challenge to be addressed appropriately.

Expected Impact

Projects funded under this Call for Proposals should:

• contribute to the achievement of SDG3 ‘Ensure healthy lives and promote well-being for all at all ages’
• lead to improvements in patient care through early detection and treatment of disease and/or enhanced monitoring and tracking of disease progression and therapeutic response
• contribute towards the implementation of innovative, rapid and simple diagnostics that can be deployed at low cost in health systems in resource-poor settings
• contribute to reduce infections by key antimicrobial resistant microorganisms in humans as recommended by the Global Action Plan Against Antimicrobial Resistance and by the European Action Plan Against Antimicrobial Resistance (AMR) 2017
• be in line with EDCTP’s strategic research agenda to be considered as having a higher impact.

Eligibility Criteria

A proposal/application will only be considered eligible if:

• its content corresponds, wholly or in part, to the topic/contest description for which it is submitted
• it complies with the eligibility conditions set out below, depending on the type of action:
  • Consortia comprising a minimum of three independent legal entities are eligible to apply. Two of the legal entities shall be established in two different Participating States (European Partner States) and one of the legal entities must be established in a sub-Saharan African country. All three legal entities shall be independent of each other.
  • ‘Sole participants’ formed by several legal entities (e.g. European Research Infrastructure Consortia, European Groupings of Territorial Cooperation, central purchasing bodies) are eligible if the above-mentioned minimum conditions are satisfied by the legal entities forming together the sole participant.

How to Apply

Interested applicants must apply online via given website.

For more information, please visit EDCTP.